| 13.41 1.035 (8.36%) | 01-08 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 21.25 | 1-year : | 24.82 |
| Resists | First : | 18.2 | Second : | 21.25 |
| Pivot price | 9.97 |
|||
| Supports | First : | 10.7 |
Second : | 6.07 |
| MAs | MA(5) : | 12.89 |
MA(20) : | 10.43 |
| MA(100) : | 7.13 |
MA(250) : | 406.15 |
|
| MACD | MACD : | 1.2 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 82.2 |
D(3) : | 80.6 |
| RSI | RSI(14): 65.5 |
|||
| 52-week | High : | 2550 | Low : | 2.88 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PLRZ ] has closed below upper band by 11.4%. Bollinger Bands are 127.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 25 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 13.6 - 13.67 | 13.67 - 13.73 |
| Low: | 12.16 - 12.23 | 12.23 - 12.3 |
| Close: | 13.3 - 13.41 | 13.41 - 13.52 |
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Thu, 08 Jan 2026
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™ - The Manila Times
Thu, 08 Jan 2026
Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mon, 05 Jan 2026
Lab test hints at new nasal barrier to block dust mite allergy triggers - Stock Titan
Fri, 05 Dec 2025
Polyrizon Ltd. Announces $4.97 Million Securities Offering - TipRanks
Thu, 04 Dec 2025
Polyrizon Surges: A Game-Changer in Progress? - StocksToTrade
Thu, 04 Dec 2025
Polyrizon Stock Skyrockets: What Sparked This Surge? - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 19.9 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 176 (K) |
| Shares Short P.Month | 32 (K) |
| EPS | -1.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.75 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -22.3 % |
| Return on Equity (ttm) | -12.2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -3.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -11 |
| PEG Ratio | 0 |
| Price to Book value | 0.71 |
| Price to Sales | 0 |
| Price to Cash Flow | -5.31 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |